Cargando…
Harmol promotes α-synuclein degradation and improves motor impairment in Parkinson’s models via regulating autophagy-lysosome pathway
The abnormal accumulation of α-synuclein (α-syn) is a crucial factor for the onset and pathogenesis of Parkinson’s disease (PD), and the autophagy-lysosome pathway (ALP) contributes to α-syn turnover. AMP-activated protein kinase (AMPK) and the mammalian target of rapamycin (mTOR) regulate autophagy...
Autores principales: | Xu, Jie, Ao, Yun-Lin, Huang, Chunhui, Song, Xiubao, Zhang, Guiliang, Cui, Wei, Wang, Yuqiang, Zhang, Xiao-Qi, Zhang, Zaijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357076/ https://www.ncbi.nlm.nih.gov/pubmed/35933473 http://dx.doi.org/10.1038/s41531-022-00361-4 |
Ejemplares similares
-
Harmol hydrochloride dihydrate induces autophagy in neuro cells and promotes the degradation of α‐Syn by Atg5/Atg12‐dependent pathway
por: Abulimiti, Gulinuer, et al.
Publicado: (2022) -
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
por: Rivero-Ríos, Pilar, et al.
Publicado: (2016) -
Transcription factor EB agonists from natural products for treating human diseases with impaired autophagy-lysosome pathway
por: Xu, Jie, et al.
Publicado: (2020) -
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
por: Limanaqi, Fiona, et al.
Publicado: (2019) -
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
por: Tang, Qilin, et al.
Publicado: (2021)